news
The loss of the tumour suppressor gene PTEN has been…
17 May 2017 | By Niamh Marriott (Drug Target Review)
The loss of the tumour suppressor gene PTEN has been linked to tumour growth and chemotherapy resistance in the almost invariably lethal brain cancer glioblastoma multiforme (GBM).